The content is available as a PDF (737.1 KB).
Contributor Information
Stanley Perlman, Email: Stanley-Perlman@uiowa.edu
Kathryn V. Holmes, Email: Kathryn.Holmes@ucHSC.edu
References
- 1.Marten NW, Stohlman SA, Bergmann CC. MHV infection in the CNS: mechanisms of immune-mediated control. Viral Immun. 2001;14:1–18. doi: 10.1089/08828240151061329. [DOI] [PubMed] [Google Scholar]
- 2.Lin MT, Hinton DR, Marten NW, Bergmann CC, Stohlman SA. Antibody prevents virus reactivation within the central nervous system. J. Immun. 1999;162:7358–7368. [PubMed] [Google Scholar]
- 3.Parra B, Hinton DR, Marten NW, Bergmann CC, Lin MT, Yang CS, Stohlmann SA. IFN-gamma is required for viral clearance from central nervous system oligodendroglia. J. Immunol. 1999;162:1641–1647. [PubMed] [Google Scholar]
- 4.Bergmann CC, Parra B, Hinton DR, Ramakrishna C, Dowdell KC, Stohlman SA. Perforin and gamma-interferon mediated control of coronavirus central nervous system infection by CD8 T cells in the absence of CD4 T cells. J. Virol. 2004;78:1739–1750. doi: 10.1128/JVI.78.4.1739-1750.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Griffin DE. Immune responses to RNA-virus infections of the CNS. Nat. Rev. Immum. 2003;3:493–502. doi: 10.1038/nri1105. [DOI] [PMC free article] [PubMed] [Google Scholar]
